The Multiple Sclerosis Association of America Releases Updated Mobile Phone App
The Multiple Sclerosis Association of America (MSAA) has updated its smartphone app My MS Manager with several new features.
Articles by Charles Moore
Novartis Pharma Program Helping Young People with MS Get And Keep Jobs
Most employers these days talk about having workforce diversity oriented policies that support hiring people living with disabilities and chronic…
Compassionate Care Center of New York Applies For for Medical Marijuana Production License
Compassionate Care Center of New York (CCCNY), based in Newark, Wayne County, is applying to become one of five…
Study Outlines Alarming Inflation Of MS Drug Costs Over Past Two Decades
Researchers at Oregon Health & Science University (OHSU) College of Pharmacy and Oregon State University (OSU) at Corvallis, and…
CorTechs Labs And Novartis Partner On Solutions for Quantifying Brain Volume In MS Patients
San Diego based medical software developer CorTechs Labs announced that it has entered into a partnership agreement with multinational pharmaceutical maker…
PatientsLikeMe/Biogen Study Evaluates Wearable Devices To Monitors Activity Of People With MS
Cambridge, Massachusetts based PatientsLikeMe has released results of a novel study conducted in conjunction with pharmaceutical maker Biogen that…
Amarantus Advancing MSPrecise For Improved Diagnosis of Relapsing-Remitting MS
Amarantus BioScience Holdings, Inc. (Amarantus) is a San Francisco based, development-stage, publicly-traded biotechnology company focused on discovering and developing…
MedDay Updates Status Of Pioneering Pivotal Phase III Study Design In Progressive Multiple Sclerosis
MedDay, a Paris, France based biotechnology company specializing in treatment of neurological disorders, has released more information regarding the…
SPMS Drug Developer Opexa Therapeutics To Receive $3M Payment from Merck Serono Under Amended Agreement
Opexa Therapeutics, Inc. a biopharmaceutical company headquartered in Woodlands, Texas, has announced the successful conclusion of negotiations…
Caffeine In Coffee Found To Reduce Multiple Sclerosis Risk
Coffee Drinking may confer the side-benefit of lowering the risk of developing multiple sclerosis (MS) in susceptible individuals, according…
Leading Developer Of Cannabis-Based Therapeutics Nemus To Address MS, Other Unmet Medical Needs
The 2012 and 2014 ballots approving legalization of cannabis in four U.S. states have stirred the pot, so to…
Biogen Idec Enters Big Data Collaborations WIth Google and Imperial College London To Better Understand MS
A report by Bloomberg News‘ Caroline Chen says multinational biotech firm Biogen Idec Inc. is teaming…
Did Misdiagnosed, Maltreated MS Cause Oscar Wilde’s Wife’s Mysterious Illness & Premature Death?
Irish poet, playwright,wit, design critic, and controversialist Oscar Wilde (1854-1900) was one of the giants of the literary scene in the…
Takeda Submits Application For New Multiple Sclerosis Relapse Prevention Drug Glatiramer Acetate in Japan
Takeda Pharmaceutical Company Limited (Takeda) announced late last month its New Drug Application (NDA) to Japan’s Ministry of…
Nova Scotia First Of Canada’s Atlantic Provinces To Fund Aubagio Treatment For Relapsing Remitting Multiple Sclerosis
Canada has one of the world’s highest Multiple Sclerosis (MS) prevalence rates. Some 100,000 Canadians live with the disease, and…
Three Years After Stem Cell Transplant Therapy Most MS Patient Subjects Still In Remission
A new study published online before print in the journal JAMA Neurology reports that three years on, most members…
Can Big Data Lead to Better MS Outcomes?
In a new study, researchers based at the Imperial College, London will follow in unprecedented detail the events and…
Province Of Ontario Funds Genzyme’s AUBAGIO For Relapsing Remitting Multiple Sclerosis
With 100,000 Canadians living with Multiple Sclerosis (MS), and three people newly diagnosed every day, Canada has one of the…
Genzyme’s Lemtrada Approved by the FDA
Cambridge, Massachusetts based Genzyme announced Friday that the U.S. Food and Drug Administration (FDA) has approved the company’s new drug…
Sailboat Crewed by MS Patients Circumnavigating the Globe
Oceans of Hope, a 67-foot sail yacht currently docked at North Cove Marina, New York, is on a round-the-world…
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
New Zealand and Australia-based Innate Immunotherapeutics Limited, a medical biotechnology company with offices in Sydney and Auckland, has…
Vitamin D Deficiency Found Highly Prevalent Across the Board in MS, Neuromuscular Disease
A study presented at the 61st annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) held…
Australian Secondary Progressive MS Clinical Trial Tests New Microparticle Therapy
New Zealand and Australia-based Innate Immunotherapeutics Limited, a biotechnology company with offices in Sydney and Auckland, has designed…
Québec Government Covers Lemtrada Second-line Treatment For Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi company, has announced that the Canadian province of Québec’s Institut national d’excellence en santé et services…
$31.4 Million in Funding Earmarked For Progressive Multiple Sclerosis Research
The first round of 22 research grants have been awarded to projects in nine countries by the International Progressive…
New MRI Study Shows Strong Correlation Of Gray Matter Myelin Loss To MS Disability
Loss of myelin, the fatty protective sheath around nerve fibers, is a characteristic of multiple sclerosis (MS). A new magnetic…
MS Researchers Find Wii Balance Board Use Improves Balance
New research published online ahead of print in the Radiological Society of North America (RSNA) journal…
Wales First U.K. Country To Approve Cannabis-Based Medicine for MS Patients
Welsh health minister Mark Drakeford has announced that Wales has become the first UK country to authorize a…
Ireland Eases Medical Marijuana For MS Restrictions; Canada Cracks Down; US States Legalize; Researchers Debate
The Republic of Ireland is legalizing the medical prescription of cannabis for people with Multiple Sclerosis, under a new…
MS And Insect Borne Disease Danger: What Works And What Doesn’t Profiled
An Everyday Health blog by New Jersey-based husband and wife team Brad and Robynn Mann notes that more time…